Jennifer Kelly, M.P.H., Ph.D.

Jennifer Kelly, M.P.H., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester, NY 14642

Office: (585) 276-5790

Research Bio

I am interested in the relationship between modifiable lifestyle factors and cancer. My research to date has been primarily focused on the potential influence of vitamin D on lymphoma risk and prognosis. Also, as a member of the Lymphoma Research Group, I collaborate on a variety of different projects, including planning and analysis of clinical trial correlative studies and translation of laboratory findings into observational research in human populations.

Awards & Honors (Local)

National Cancer Institute Career Development Award (K07) 2012
Lymphoma Research Foundation Fellowship Grant 2011
NIH Loan Repayment Program Award 2010
University of Rochester School of Medicine and Dentistry Medical Faculty Council Trainee Travel Award 2009
University of Rochester Lymphoma SPORE Career Development Award 2009

Recent Journal Articles

Showing the 5 most recent journal articles. 16 available »

2012 Jul
Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, Feldman AL, Ansell SM, Macon WR, Herr MM, Wang AH, Nowakowski GS, Call TG, Habermann TM, Slager SL, Witzig TE, Cerhan JR. "Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma." Cancer causes & control : CCC. 2012 Jul; 23(7):1017-29. Epub 2012 Apr 28.
2012 Jun
Biswas T, Culakova E, Friedberg JW, Kelly JL, Dhakal S, Liesveld J, Phillips GL, Constine LS. "Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma." Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2012 Jun; 103(3):367-72. Epub 2012 Mar 05.
2012 May
Ban-Hoefen M, Kelly JL, Bernstein SH, Liesveld J, Constine L, Becker M, Milner L, Phillips G, Friedberg JW. "High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era." Leukemia & lymphoma. 2012 May; 53(5):830-5. Epub 2011 Dec 06.
2012 Apr
Keller SF, Kelly JL, Sensenig E, Andreozzi J, Oliva J, Rich L, Constine L, Becker M, Phillips G, Liesveld J, Fisher RI, Bernstein SH, Friedberg JW. "Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic era." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Apr; 18(4):640-7. Epub 2011 Aug 24.
2012 Mar
Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung J, Sanz I, Friedberg JW. "Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion." Clinical immunology : the official journal of the Clinical Immunology Society. 2012 Mar; 142(3):237-42. Epub 2012 Jan 05.


PhD | Epidemiology | University of Rochester2008
MPH | Public Health | University of Rochester2004
BS | Biology | Cornell University1998

Post-Doctoral Training & Residency

Postdoctoral Research Associate, Hematology Research Training Program, University of Rochester School of Medicine and Dentistry, Rochester, New York 2010